Current Oncology, Vol 23, Suppl 2 - Now Published!
Use of Cannabinoids in Cancer Care
Multimed Inc. is pleased to announce that Current Oncology has published a supplement dedicated to the use of cannabinoids in cancer care.Edited by Dr. Mark Ware, this issue brings together the work of some of the leading minds around the world who have dedicated themselves and their laboratories to understanding the role of cannabis and cannabinoids in the pathophysiology and management of cancer. This collection of papers takes us on a journey from bedside to bench and back, and provides a series of important signposts that will help to chart a path to better cancer care.
We would like to thank all of the contributing authors for their work on this special supplement. We would also like to send a special thank you to Dr. Mark Ware for his hard work and dedication in bringing this supplement to fruition.
Publication of this supplement was made possible through an unrestricted grant from Mettrum to the Canadian Consortium for the Investigation of Cannabinoids (CCIC). We sincerely thank Mettrum for their support of this project and for their ongoing commitment to research and education in cannabinoid medicine.
To view the full Table of Contents, please click here.